Kommerell憩室移植替换术及迷走锁骨下动脉原位重建
本研究评估成人Kommerell憩室移植替换及迷走锁骨下动脉原位重建的早期与远期结果。17例患者(6例有症状,11例右主动脉弓)于1999年10月至2017年9月接受开放手术,住院死亡1例(5.9%),无永久性神经功能缺损,5年和10年生存率分别为85.2±9.8%和75.8±12.5%,无复发性症状或重建锁骨下动脉狭窄。
要点
- 17例成人Kommerell憩室患者接受开放移植替换及迷走锁骨下动脉原位重建。
- 住院死亡1例(5.9%),为破裂动脉瘤行全主动脉弓替换者。
- 无永久性神经功能缺损,短暂性神经功能缺损2例(11.8%)。
核心结论
- Kommerell憩室移植替换及迷走锁骨下动脉原位重建的早期结果可接受。
- 远期有症状改善及重建迷走锁骨下动脉的优秀通畅率,提示原位手术修复是有效的治疗选择。
研究设计与样本
- 回顾性评估成人Kommerell憩室移植替换及迷走锁骨下动脉原位重建的早期和远期结果。
- 1999年10月至2017年9月,17例患者接受开放修复,其中6例有症状,11例为右主动脉弓。
- 2例患者因破裂动脉瘤接受开放手术治疗。
- 手术指征为Kommerell动脉瘤扩张(n=9)、Kommerell憩室合并非夹层动脉瘤(n=6)、急性A型主动脉夹层(n=1)和复杂性急性B型主动脉夹层(n=1)。
- 10例经胸廓切开行全主动脉弓替换和降主动脉替换,5例经正中胸骨切开行主动脉弓替换和原位重建。
主要发现
- 住院死亡1例(5.9%),该患者因破裂动脉瘤行全主动脉弓替换。
- 无永久性神经功能缺损,短暂性神经功能缺损2例(11.8%)。
- 5年和10年生存率分别为85.2±9.8%和75.8±12.5%。
- 无复发性症状或重建锁骨下动脉狭窄。
临床怎么用
- 作者认为,对于Kommerell憩室及迷走锁骨下动脉,原位手术修复是有效的治疗选择。
- 作者认为,Kommerell憩室移植替换及迷走锁骨下动脉原位重建的早期结果可接受。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study aimed to evaluate the early and long-term outcomes of graft replacement of Kommerell diverticulum and in situ reconstruction of aberrant subclavian arteries in adults. METHODS: Seventeen patients, 6 symptomatic and 11 with right aortic arch, underwent open repair of Kommerell diverticulum from October 1999 to September 2017. Two of these patients underwent open surgical treatment of a ruptured aneurysm. Surgical indications were dilatation of Kommerell aneurysm (n = 9), the presence of a nondissecting aneurysm with Kommerell diverticulum (n = 6), acute type A aortic dissection (n = 1), and complicated acute type B aortic dissection (n = 1). Ten patients underwent total arch replacement and descending aorta replacement through a thoracotomy. Five patients underwent arch replacement and in situ reconstruction through a median sternotomy. All patients except 1 also underwent in situ reconstruction of their aberrant subclavian artery. RESULTS: In-hospital death occurred in 1 patient (5.9%), who underwent total arch replacement for a ruptured aneurysm. Permanent neurologic deficit did not occur in any patient, whereas transient neurologic deficit occurred in 2 patients (11.8%). Five- and 10-year survival rates were 85.2 ± 9.8% and 75.8 ± 12.5%, respectively. There was no symptom recurrence or stenosis of the reconstructed subclavian arteries. CONCLUSIONS: Early outcomes of graft replacement of Kommerell diverticulum and in situ aberrant subclavian artery reconstruction were acceptable. As for long-term outcomes, symptomatic improvement and an excellent patency rate among reconstructed aberrant subclavian arteries suggest that in situ surgical repair is an effective treatment option.
引用
- Ikeno Y, Koda Y, Yokawa K, et al. Graft Replacement of Kommerell Diverticulum and In Situ Aberrant Subclavian Artery Reconstruction. Ann Thorac Surg. 2018. PMID: 30218662. doi:10.1016/j.athoracsur.2018.07.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。